Eledon Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Eledon Pharmaceuticals valuation and funding history | Last updated: December 16, 2020 | 2 funding rounds
Current Valuation
N/A
As of December 16, 2020
Total Funding Raised
N/A
Across 2 rounds
Last Round
PIPE
$108.0M
Last Funding
Dec 2020
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| December 16, 2020 | PIPE | $108.0M | N/A | - |
| November 12, 2024 | PIPE | $67.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Eledon Pharmaceuticals is currently valued at N/A as of December 16, 2020.
Explore More Data
Detailed analysis for Eledon Pharmaceuticals
What is Eledon Pharmaceuticals Worth in 2026?
Eledon Pharmaceuticals is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Eledon Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Eledon Pharmaceuticals Valuation is Determined
Private company valuations like Eledon Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.